Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Westenberg

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Acta Psychiatrica Scandinavica|April 1, 1986
A comparative study on the antipsychotic properties of desenkephalin-gamma-endorphin and ceruletide in schizophrenic patientsW M Verhoeven, H G Westenberg, J M van Ree
Peptides|January 1, 1992
The MSH/ACTH analog ORG 2766 in anxiety disordersJ A Den Boer, H G Westenberg, H De Vries
L'Encephale|January 1, 1984
[Biological determinants of schizophrenic psychoses]W M Verhoeven, H G Westenberg, J M Van Ree
Neuropediatrics|October 1, 1984
Treatment of non-fluctuating progressive dystonia: a neuropharmacological approachJ Willemse, O van Nieuwenhuizen, R H Gooskens, et al.
Psychopharmacology|January 1, 1993
MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled studyI M van Vliet, H G Westenberg, J A Den Boer
Acta Neuropsychiatrica|March 10, 2016
Neuropeptides and anxiety disordersH J van Megen, J A den Boer, H G Westenberg
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1994
Recent advances in the psychopharmacology of social phobiaJ A Den Boer, I M Van Vliet, H G Westenberg
Psychopharmacology|June 1, 1994
Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamineI M van Vliet, J A den Boer, H G Westenberg
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1995
Recent developments in the psychopharmacology of social phobiaJ A Den Boer, I M van Vliet, H G Westenberg
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 1, 1994
On the significance of cholecystokinin receptors in panic disorderH J van Megen, J A den Boer, H G Westenberg
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Acta Psychiatrica Scandinavica|April 1, 1986
A comparative study on the antipsychotic properties of desenkephalin-gamma-endorphin and ceruletide in schizophrenic patientsW M Verhoeven, H G Westenberg, J M van Ree
Peptides|January 1, 1992
The MSH/ACTH analog ORG 2766 in anxiety disordersJ A Den Boer, H G Westenberg, H De Vries
L'Encephale|January 1, 1984
[Biological determinants of schizophrenic psychoses]W M Verhoeven, H G Westenberg, J M Van Ree
Neuropediatrics|October 1, 1984
Treatment of non-fluctuating progressive dystonia: a neuropharmacological approachJ Willemse, O van Nieuwenhuizen, R H Gooskens, et al.
Psychopharmacology|January 1, 1993
MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled studyI M van Vliet, H G Westenberg, J A Den Boer
Acta Neuropsychiatrica|March 10, 2016
Neuropeptides and anxiety disordersH J van Megen, J A den Boer, H G Westenberg
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1994
Recent advances in the psychopharmacology of social phobiaJ A Den Boer, I M Van Vliet, H G Westenberg
Psychopharmacology|June 1, 1994
Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamineI M van Vliet, J A den Boer, H G Westenberg
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1995
Recent developments in the psychopharmacology of social phobiaJ A Den Boer, I M van Vliet, H G Westenberg
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 1, 1994
On the significance of cholecystokinin receptors in panic disorderH J van Megen, J A den Boer, H G Westenberg
Pageof 10